|
US6974578B1
(en)
*
|
1993-12-28 |
2005-12-13 |
Allergan, Inc. |
Method for treating secretions and glands using botulinum toxin
|
|
US9066943B2
(en)
*
|
1997-07-15 |
2015-06-30 |
The Regents Of The University Of Colorado |
Use of botulinum toxin therapy for treatment of urological neurological conditions
|
|
US7838008B2
(en)
|
1999-12-07 |
2010-11-23 |
Allergan, Inc. |
Methods for treating diverse cancers
|
|
EP1301213B1
(en)
*
|
2000-07-21 |
2017-01-18 |
ReVance Therapeutics, Inc. |
Multi-component biological transport systems
|
|
US20040220100A1
(en)
*
|
2000-07-21 |
2004-11-04 |
Essentia Biosystems, Inc. |
Multi-component biological transport systems
|
|
WO2003047589A1
(en)
*
|
2001-11-15 |
2003-06-12 |
Micro Algae Corporation |
Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission
|
|
US7763663B2
(en)
*
|
2001-12-19 |
2010-07-27 |
University Of Massachusetts |
Polysaccharide-containing block copolymer particles and uses thereof
|
|
US7666435B2
(en)
*
|
2002-08-19 |
2010-02-23 |
Ira Sanders |
Treatment of fine wrinkles with clostridia neurotoxins
|
|
US20120114697A1
(en)
|
2002-08-19 |
2012-05-10 |
Ira Sanders |
Treatment of holocrine gland dysfunction with clostridia neurotoxins
|
|
US7824693B2
(en)
|
2002-08-19 |
2010-11-02 |
Ira Sanders |
Treatment of fine wrinkles with clostridia neurotoxins
|
|
US20040115222A1
(en)
*
|
2002-09-06 |
2004-06-17 |
Michael Kane |
Method for reduction of wrinkles
|
|
EP1599213A4
(en)
*
|
2003-02-24 |
2009-07-15 |
Ira Sanders |
CELL MEMBRANE TRANSLOCATION OF SNARE R GUL S INHIBITORS, ASSOCIATED COMPOSITIONS AND PATHOLOGY TREATMENT PROCESSES
|
|
US20040247623A1
(en)
*
|
2003-03-24 |
2004-12-09 |
Roger Cady |
Method and article for treatment of sensory neuron related disorders through transdermal application of botulinum toxin
|
|
US20040226556A1
(en)
*
|
2003-05-13 |
2004-11-18 |
Deem Mark E. |
Apparatus for treating asthma using neurotoxin
|
|
US8048423B2
(en)
*
|
2003-12-09 |
2011-11-01 |
Allergan, Inc. |
Botulinum toxin therapy for skin disorders
|
|
US8871224B2
(en)
*
|
2003-12-09 |
2014-10-28 |
Allergan, Inc. |
Botulinum toxin therapy for skin disorders
|
|
US20050191321A1
(en)
*
|
2004-02-26 |
2005-09-01 |
Allergan, Inc. |
Methods for treating headache
|
|
US20100266638A1
(en)
*
|
2004-02-26 |
2010-10-21 |
Allergan, Inc. |
Headache treatment method
|
|
CN1946431B
(zh)
|
2004-03-03 |
2011-12-07 |
雷文斯治疗公司 |
用于肉毒毒素的局部施用和透皮递送的组合物和方法
|
|
CA2558676C
(en)
|
2004-03-03 |
2019-04-16 |
Essentia Biosystems, Inc. |
Compositions and methods for topical diagnostic and therapeutic transport
|
|
US9211248B2
(en)
|
2004-03-03 |
2015-12-15 |
Revance Therapeutics, Inc. |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
|
US20080031898A1
(en)
*
|
2004-03-26 |
2008-02-07 |
David Nathaniel E |
Compositions and methods to increase the effect of a neurotoxin treatment
|
|
US20050220821A1
(en)
*
|
2004-03-31 |
2005-10-06 |
Allergan, Inc. |
Pressure sore treatment
|
|
US20050220734A1
(en)
*
|
2004-04-02 |
2005-10-06 |
Allergan, Inc. |
Therapy for melanin related afflictions
|
|
JP2007538010A
(ja)
*
|
2004-05-07 |
2007-12-27 |
ファイトトックス リミテッド |
フィコトキシンの経皮投与
|
|
WO2005110417A1
(en)
*
|
2004-05-07 |
2005-11-24 |
Phytotox Limited |
Phycotoxins and uses thereof
|
|
US7922983B2
(en)
*
|
2005-07-28 |
2011-04-12 |
Kimberly-Clark Worldwide, Inc. |
Sterilization wrap with additional strength sheet
|
|
GB2417419A
(en)
*
|
2004-07-12 |
2006-03-01 |
Ipsen Ltd |
Therapeutic use of Botulinum toxin
|
|
GB2416122A
(en)
*
|
2004-07-12 |
2006-01-18 |
Ipsen Ltd |
Botulinum neurotoxin composition
|
|
BRPI0513850A
(pt)
*
|
2004-07-26 |
2008-05-20 |
Merz Pharma Gmbh & Co Kgaa |
composição terapêutica com uma neurotoxina botulìnica
|
|
US20060024331A1
(en)
*
|
2004-08-02 |
2006-02-02 |
Ester Fernandez-Salas |
Toxin compounds with enhanced membrane translocation characteristics
|
|
US7429386B2
(en)
*
|
2004-09-03 |
2008-09-30 |
Allergan, Inc. |
Stretch mark treatment
|
|
US7179474B2
(en)
*
|
2004-09-03 |
2007-02-20 |
Allergan, Inc. |
Methods for treating a buttock deformity
|
|
CA2518650A1
(en)
*
|
2004-09-10 |
2006-03-10 |
Dimitrios Dimitrakoudis |
Clostridium botulinum toxin formulation and method for reducing weight
|
|
US7906124B2
(en)
*
|
2004-09-18 |
2011-03-15 |
Asthmatx, Inc. |
Inactivation of smooth muscle tissue
|
|
US20060073208A1
(en)
|
2004-10-01 |
2006-04-06 |
Allergan, Inc. |
Cosmetic neurotoxin compositions and methods
|
|
US7473678B2
(en)
|
2004-10-14 |
2009-01-06 |
Biomimetic Therapeutics, Inc. |
Platelet-derived growth factor compositions and methods of use thereof
|
|
US7897147B2
(en)
|
2004-10-20 |
2011-03-01 |
Allergan, Inc. |
Treatment of premenstrual disorders
|
|
FR2879462B1
(fr)
*
|
2004-12-21 |
2008-12-26 |
Sod Conseils Rech Applic |
Utilisation de toxine botulique pour une insensibilisation locale prolongee
|
|
JP2008536797A
(ja)
*
|
2004-12-29 |
2008-09-11 |
ラボ コスプロファー アクチェンゲゼルシャフト |
表情皺を緩和するのに好適な皮膚投与のための美容組成物
|
|
US7655244B2
(en)
|
2005-02-01 |
2010-02-02 |
Allergan, Inc. |
Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions
|
|
US7749515B2
(en)
*
|
2005-02-01 |
2010-07-06 |
Allergan, Inc. |
Targeted delivery of botulinum toxin to the sphenopalatine ganglion
|
|
CN101160318A
(zh)
|
2005-03-03 |
2008-04-09 |
雷文斯治疗公司 |
用于局部施用和经皮肤递送寡肽的组合物和方法
|
|
SG160357A1
(en)
|
2005-03-03 |
2010-04-29 |
Revance Therapeutics Inc |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
|
US7419675B2
(en)
*
|
2005-05-26 |
2008-09-02 |
Allergan, Inc. |
Method for treating peritoneal adhesions
|
|
BRPI0613631A8
(pt)
*
|
2005-07-18 |
2017-12-26 |
Univ Massachusetts Lowell |
nanoemulsão e método,
|
|
EP1747782A1
(en)
|
2005-07-19 |
2007-01-31 |
Cesare Montecucco |
Products for topical application comprising lysophospholipids and fatty acids
|
|
US7655243B2
(en)
|
2005-07-22 |
2010-02-02 |
The Foundry, Llc |
Methods and systems for toxin delivery to the nasal cavity
|
|
US12433837B2
(en)
|
2005-07-22 |
2025-10-07 |
The Foundry, Llc |
Systems and methods for delivery of a therapeutic agent
|
|
JP5826450B2
(ja)
|
2005-07-22 |
2015-12-02 |
ザ ファウンドリー， エルエルシー |
治療薬の送達のためのシステムおよび方法
|
|
US10052465B2
(en)
|
2005-07-22 |
2018-08-21 |
The Foundry, Llc |
Methods and systems for toxin delivery to the nasal cavity
|
|
US8168206B1
(en)
|
2005-10-06 |
2012-05-01 |
Allergan, Inc. |
Animal protein-free pharmaceutical compositions
|
|
NZ568216A
(en)
*
|
2005-11-17 |
2012-09-28 |
Revance Therapeutics Inc |
Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteins
|
|
BRPI0619134B8
(pt)
|
2005-12-01 |
2021-05-25 |
Univ Massachusetts Lowell |
nanoemulsão, composição farmacêutica, composição, métodos cosméticos para o tratamento de rugas, linhas faciais e/ou linhas do pescoço, e de retardar o início das rugas, linhas faciais e/ou linhas do pescoço, e, método de fabricação de uma nanoemulsão
|
|
US9486408B2
(en)
|
2005-12-01 |
2016-11-08 |
University Of Massachusetts Lowell |
Botulinum nanoemulsions
|
|
AU2013234398B2
(en)
*
|
2005-12-01 |
2016-05-19 |
University Of Massachusetts Lowell |
Botulinum nanoemulsions
|
|
WO2007071448A2
(en)
|
2005-12-23 |
2007-06-28 |
Partnership & Corp. Technology Transfer |
Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of muscle relaxation
|
|
US7824694B2
(en)
*
|
2006-01-12 |
2010-11-02 |
Allergan, Inc. |
Methods for enhancing therapeutic effects of a neurotoxin
|
|
EP2015773A4
(en)
*
|
2006-04-27 |
2010-05-05 |
Anterios Inc |
EXAMINATION OF THE EFFECTS OF TOPICAL ADMINISTRATION OF CHEMICALLY DENOMINATING PHARMACEUTICALS
|
|
US20090304747A1
(en)
*
|
2006-05-16 |
2009-12-10 |
Mayo Foundation For Medical Education And Research |
Use of dmso and botulinum toxin therapy for urinary incontinence and related disorders
|
|
CN101074935B
(zh)
*
|
2006-05-19 |
2011-03-23 |
清华大学 |
探测器阵列及设备
|
|
FR2902341B1
(fr)
|
2006-06-16 |
2011-02-25 |
Scras |
Utilisation therapeutique simultanee, separee ou etalee dans le temps d'au moins une neurotoxine botulique, et d'au moins un derive opiace
|
|
AR061669A1
(es)
*
|
2006-06-29 |
2008-09-10 |
Merz Pharma Gmbh & Co Kgaa |
Aplicacion de alta frecuencia de terapia con toxina botulinica
|
|
FR2907680B1
(fr)
|
2006-10-27 |
2012-12-28 |
Scras |
Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur induite par au moins un agent anti-cancereux
|
|
US7445783B2
(en)
*
|
2006-10-30 |
2008-11-04 |
Cappellos, Inc. |
Topical and transdermal treatments using urea formulations
|
|
SG10201607909WA
(en)
*
|
2006-12-01 |
2016-11-29 |
Anterios Inc |
Peptide nanoparticles and uses therefor
|
|
WO2008070538A2
(en)
*
|
2006-12-01 |
2008-06-12 |
Anterios, Inc. |
Micellar nanoparticles comprising botulinum toxin
|
|
FR2910327B1
(fr)
|
2006-12-22 |
2013-04-26 |
Scras |
Utilisation d'au moins une neurotoxine botulique pour traiter la douleur induite par les traitements therapeutiques du virus du sida.
|
|
US20100021502A1
(en)
*
|
2006-12-28 |
2010-01-28 |
Waugh Jacob M |
Compositions and Methods of Topical Application and Transdermal Delivery of Botulinum Toxins Stabililzed with Polypeptide Fragments Derived from HIV-TAT
|
|
NZ598159A
(en)
*
|
2006-12-29 |
2013-08-30 |
Revance Therapeutics Inc |
Transport molecules using reverse sequence hiv-tat polypeptides
|
|
JP2010514781A
(ja)
*
|
2006-12-29 |
2010-05-06 |
ルバンス セラピュティックス インク． |
Ｈｉｖ−ｔａｔに由来するポリペプチド断片を用いて安定化されるボツリヌス毒素を局所適用及び経皮送達する組成物及び方法
|
|
WO2008151022A2
(en)
|
2007-05-31 |
2008-12-11 |
Anterios, Inc. |
Nucleic acid nanoparticles and uses therefor
|
|
CN101842107B
(zh)
|
2007-07-26 |
2014-04-23 |
雷文斯治疗公司 |
抗微生物肽，组合物和使用方法
|
|
WO2009021232A2
(en)
*
|
2007-08-09 |
2009-02-12 |
Massachusetts Institute Of Technology |
High-throughput, whole-animal screening system
|
|
EP2211890A1
(en)
*
|
2007-10-23 |
2010-08-04 |
Allergan, Inc. |
Methods of treating urogenital-neurological disorders using modified clostridial toxins
|
|
US8483831B1
(en)
|
2008-02-15 |
2013-07-09 |
Holaira, Inc. |
System and method for bronchial dilation
|
|
US9107815B2
(en)
*
|
2008-02-22 |
2015-08-18 |
Allergan, Inc. |
Sustained release poloxamer containing pharmaceutical compositions
|
|
US8470337B2
(en)
*
|
2008-03-13 |
2013-06-25 |
Allergan, Inc. |
Therapeutic treatments using botulinum neurotoxin
|
|
US8617571B2
(en)
*
|
2008-04-03 |
2013-12-31 |
Allergan, Inc. |
Suture line administration technique using botulinum toxin
|
|
FR2930447B1
(fr)
|
2008-04-25 |
2010-07-30 |
Sod Conseils Rech Applic |
Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur dans le cas de la neuropathie diabetique
|
|
US8088127B2
(en)
|
2008-05-09 |
2012-01-03 |
Innovative Pulmonary Solutions, Inc. |
Systems, assemblies, and methods for treating a bronchial tree
|
|
MX379265B
(es)
|
2008-06-26 |
2025-03-11 |
Anterios Inc |
Aplicacion dérmica de toxina botulínica en nanoemulsiones para usarse en el tratamiento de trastornos de la piel.
|
|
US8697155B2
(en)
*
|
2008-07-22 |
2014-04-15 |
Mayo Foundation For Medical Education And Research |
Treatment of obesity and related disorders
|
|
DE102008034453A1
(de)
*
|
2008-07-24 |
2010-02-11 |
Lts Lohmann Therapie-Systeme Ag |
Verfahren zum Herstellen eines Mehrschichtenverbundes auf einer CIP-fähigen Beschichtungsanlage und Verwendung des damit hergestellten Mehrschichtenverbundes für die transdermale Applikation oder die Applikation in Körperhöhlen
|
|
US20100028385A1
(en)
*
|
2008-08-04 |
2010-02-04 |
Allergan, Inc. |
Treatment of excess cerumen secretion
|
|
AU2009332947C1
(en)
|
2008-12-31 |
2019-01-03 |
Revance Therapeutics, Inc. |
Injectable botulinum toxin formulations
|
|
KR101959234B1
(ko)
*
|
2009-04-01 |
2019-03-18 |
레반스 테라퓨틱스, 아이엔씨. |
혈관 과민반응과 관련된 피부질환을 치료하기 위한 방법 및 조성물
|
|
EP2248518B1
(en)
|
2009-04-17 |
2013-01-16 |
Merz Pharma GmbH & Co. KGaA |
Formulation for stabilizing proteins, peptides or mixtures thereof.
|
|
EP2445521A4
(en)
|
2009-06-25 |
2015-08-26 |
Revance Therapeutics Inc |
ALBUMINE-FREE BOTULINUM TOXIN FORMULATIONS
|
|
BR112012003834A2
(pt)
|
2009-08-21 |
2017-08-08 |
Targeted Delivery Tech Limited |
métodos para tratamento de distúrbios e para tratamentos de deficiências em ácidos graxos, hipertrigliceridemia ou hipercolesterolemia e pacote
|
|
US8147848B2
(en)
|
2009-08-26 |
2012-04-03 |
Allergan, Inc. |
Method for treating premature ejaculation with a botulinum neurotoxin
|
|
WO2011038015A1
(en)
|
2009-09-24 |
2011-03-31 |
Allergan, Inc. |
Method of treating osteoporosis with a neurotoxin
|
|
AU2010315396B2
(en)
|
2009-10-27 |
2016-05-05 |
Nuvaira, Inc |
Delivery devices with coolable energy emitting assemblies
|
|
JP6000851B2
(ja)
|
2009-11-11 |
2016-10-05 |
ホライラ， インコーポレイテッド |
組織治療および狭窄制御のためのシステム、装置、および方法
|
|
US8911439B2
(en)
*
|
2009-11-11 |
2014-12-16 |
Holaira, Inc. |
Non-invasive and minimally invasive denervation methods and systems for performing the same
|
|
JP5990176B2
(ja)
|
2010-10-12 |
2016-09-07 |
メルツ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディト ゲゼルシャフト アウフ アクティーン |
タンパク質の安定化に好適な哺乳動物性賦形剤非含有製剤
|
|
US20120189677A1
(en)
*
|
2011-01-20 |
2012-07-26 |
Stephen Tonge |
Formulations
|
|
KR20140005998A
(ko)
|
2011-01-24 |
2014-01-15 |
안테리오스, 인코퍼레이티드 |
나노입자 조성물, 이의 제형, 및 그의 용도
|
|
EP2667854B1
(en)
|
2011-01-24 |
2019-01-16 |
Anterios, Inc. |
Nanoparticle compositions
|
|
EP2691101A2
(en)
|
2011-03-31 |
2014-02-05 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
|
US8697090B2
(en)
|
2011-05-05 |
2014-04-15 |
Allergan, Inc. |
Method of treating persistent genital arousal disorder with a neurotoxin
|
|
EP2724725B1
(en)
*
|
2011-06-27 |
2016-09-07 |
Sang Duck Kim |
Pharmaceutical composition for use in treating scars on the skin
|
|
US20170360867A1
(en)
*
|
2011-11-11 |
2017-12-21 |
Nova Neura, Llc |
Pain Relieving System
|
|
CN104114572A
(zh)
|
2011-12-16 |
2014-10-22 |
现代治疗公司 |
经修饰的核苷、核苷酸和核酸组合物
|
|
ES2424294B1
(es)
|
2012-03-22 |
2014-07-21 |
Lipotec, S.A. |
Exopolisacárido para el tratamiento y/o cuidado de la piel, mucosas, cabello y/o uñas
|
|
GB201205642D0
(en)
|
2012-03-29 |
2012-05-16 |
Sequessome Technology Holdings Ltd |
Vesicular formulations
|
|
EP2836193B1
(en)
|
2012-04-13 |
2018-01-31 |
Lubrizol Advanced Materials, Inc. |
Compounds which inhibit neuronal exocytosis (ii)
|
|
EP2649985A1
(en)
|
2012-04-13 |
2013-10-16 |
Lipotec, S.A. |
Compounds which inhibit neuronal exocytosis (III)
|
|
EP2649983A1
(en)
|
2012-04-13 |
2013-10-16 |
Lipotec, S.A. |
Compounds which inhibit neuronal exocytosis (II)
|
|
EP2649984A1
(en)
|
2012-04-13 |
2013-10-16 |
Lipotec, S.A. |
Compounds which inhibit neuronal exocytosis
|
|
GB201208384D0
(en)
*
|
2012-05-14 |
2012-06-27 |
Sequessome Technology Holdings Ltd |
Vesicular formulations, uses and methods
|
|
US9205204B2
(en)
|
2012-08-06 |
2015-12-08 |
Elwha Llc |
Devices and methods for wearable injection guides
|
|
RU2506054C1
(ru)
*
|
2012-10-22 |
2014-02-10 |
Елена Александровна Рогожкина |
Способ лечения хронической анальной трещины
|
|
CA2889833A1
(en)
|
2012-10-28 |
2014-05-01 |
Revance Therapeutics, Inc. |
Compositions and methods for safe treatment of rhinitis
|
|
WO2014081507A1
(en)
|
2012-11-26 |
2014-05-30 |
Moderna Therapeutics, Inc. |
Terminally modified rna
|
|
US9398933B2
(en)
|
2012-12-27 |
2016-07-26 |
Holaira, Inc. |
Methods for improving drug efficacy including a combination of drug administration and nerve modulation
|
|
US20140200261A1
(en)
|
2013-01-17 |
2014-07-17 |
Moderna Therapeutics, Inc. |
Signal-sensor polynucleotides for the alteration of cellular phenotypes
|
|
EP2968391A1
(en)
|
2013-03-13 |
2016-01-20 |
Moderna Therapeutics, Inc. |
Long-lived polynucleotide molecules
|
|
BR112015024221A2
(pt)
|
2013-03-22 |
2017-07-18 |
Lipotec Sa |
exopolissacarídeo, uso do exopolissacarídeio, e, composição cosmética ou dermofarmacêutica
|
|
US10149893B2
(en)
|
2013-09-24 |
2018-12-11 |
Allergan, Inc. |
Methods for modifying progression of osteoarthritis
|
|
US20160279401A1
(en)
|
2015-03-27 |
2016-09-29 |
Allergan, Inc. |
Dissolvable microneedles for skin treatment
|
|
CA2949653C
(en)
*
|
2014-05-29 |
2019-12-17 |
Procell Therapeutics Inc. |
Novel cell penetrating peptide, conjugate thereof with botulinum toxin, and use thereof
|
|
US11484580B2
(en)
|
2014-07-18 |
2022-11-01 |
Revance Therapeutics, Inc. |
Topical ocular preparation of botulinum toxin for use in ocular surface disease
|
|
PL3284506T3
(pl)
*
|
2015-04-13 |
2021-10-25 |
Lg Household & Health Care Ltd. |
Rozpuszczalna mikroigła zawierająca składnik do kontroli uwalniania neuroprzekaźników
|
|
WO2016167545A1
(ko)
*
|
2015-04-13 |
2016-10-20 |
주식회사 엘지생활건강 |
신경전달물질의 배출을 조절하는 성분이 포함된 용해성 마이크로니들
|
|
KR102203633B1
(ko)
*
|
2015-04-14 |
2021-01-15 |
주식회사 엘지생활건강 |
칼슘채널 차단제 전달용 용해성 미세바늘
|
|
PL3316856T3
(pl)
|
2015-06-30 |
2021-10-25 |
Sequessome Technology Holdings Limited |
Zmieszane formulacje
|
|
WO2017063743A1
(en)
*
|
2015-10-14 |
2017-04-20 |
Merz Pharma Gmbh & Co. Kgaa |
Improvements to ultrasound-based therapy of photoaged tissue
|
|
US20170209553A1
(en)
*
|
2016-01-22 |
2017-07-27 |
Transderm, Inc. |
Delivery of botulinum with microneedle arrays
|
|
KR101876177B1
(ko)
*
|
2016-02-17 |
2018-07-09 |
가톨릭관동대학교산학협력단 |
경피투과 보툴리눔 독소 패치
|
|
BR112019004935A2
(pt)
|
2016-09-13 |
2019-06-04 |
Allergan, Inc. |
composições de toxina clostridial não proteíca estabilizada
|
|
AU2017360346B2
(en)
*
|
2016-11-21 |
2023-11-23 |
Eirion Therapeutics, Inc. |
Transdermal delivery of large agents
|
|
WO2018151832A1
(en)
|
2017-02-17 |
2018-08-23 |
Allergan, Inc. |
Microneedle array with active ingredient
|
|
JP7604222B2
(ja)
*
|
2017-03-22 |
2024-12-23 |
ボンチ インコーポレイテッド |
治療用のボツリヌス神経毒素
|
|
CN106890196A
(zh)
*
|
2017-04-07 |
2017-06-27 |
青岛东海药业有限公司 |
酪酸梭菌在制备预防或治疗帕金森病制剂中的应用
|
|
EP3641746B1
(en)
|
2017-06-19 |
2024-11-20 |
President And Fellows Of Harvard College |
Methods and compositions for treating a microbial infection
|
|
US10792400B2
(en)
|
2017-10-12 |
2020-10-06 |
Hugel Inc. |
Microstructure formulation techniques for botulinum toxin
|
|
US10525111B2
(en)
|
2017-10-12 |
2020-01-07 |
Hugel, Inc. |
Microstructure formulation techniques for botulinum toxin
|
|
US20190185837A1
(en)
|
2017-12-20 |
2019-06-20 |
Allergan, Inc. |
Botulinum toxin cell binding domain polypeptides and methods of use for treatments of fibrosis associated disorders
|
|
EP3843777A4
(en)
|
2018-08-28 |
2022-05-04 |
Ira Sanders |
THERAPEUTICS FOR THE SKIN
|
|
CN118121545A
(zh)
*
|
2018-11-19 |
2024-06-04 |
奥维嘉生物科技（北京）有限公司 |
一种制备柔性脂质体的方法
|
|
BR112021009554A2
(pt)
|
2018-12-03 |
2021-08-17 |
Eirion Therapeutics, Inc. |
aplicação melhorada de agentes grandes
|
|
AU2020226653B2
(en)
*
|
2019-02-20 |
2025-09-18 |
Regresar Medical, Inc. |
Methods and devices for localizing compositions
|
|
WO2020231700A1
(en)
*
|
2019-05-11 |
2020-11-19 |
Youngsuk Yi |
Neurotoxin compositions and methods
|
|
CA3139983A1
(en)
|
2019-05-14 |
2020-11-19 |
Eirion Therapeutics, Inc. |
Delaying peak effect and/or extending duration of response
|
|
KR102427362B1
(ko)
*
|
2021-11-11 |
2022-08-01 |
(주)이니바이오 |
보툴리눔 독소 제제의 건조 공정
|
|
WO2026053109A1
(en)
*
|
2024-09-03 |
2026-03-12 |
B. G. Negev Technologies And Applications Ltd., At Ben-Gurion University |
Methods for enhancing transdermal delivery of botulinum toxins
|